Results 201 to 210 of about 492,944 (298)
Final Analysis of the BRUIN Phase 1/2 Study Assessing the Safety and Efficacy of Pirtobrutinib Monotherapy in Patients With MCL
American Journal of Hematology, EarlyView.ABSTRACT
Pirtobrutinib, a highly selective, non‐covalent Bruton tyrosine kinase inhibitor (BTKi) previously demonstrated durable efficacy and tolerable safety following covalent (c) BTKi therapy in heavily pretreated relapsed/refractory (R/R) mantle cell lymphoma (MCL).Michael L. Wang, Jonathon B. Cohen, Nirav N. Shah, Wojciech Jurczak, Pier Luigi Zinzani, Chan Y. Cheah, Chaitra S. Ujjani, Youngil Koh, Won Seog Kim, Sunita D. Nasta, Ian Flinn, Benoit Tessoulin, Shuo Ma, Alvaro J. Alencar, David J. Lewis, Jennifer A. Woyach, Kami J. Maddocks, Krish Patel, Yucai Wang, Joanna M. Rhodes, Constantine S. Tam, John F. Seymour, Hirokazu Nagai, Julie M. Vose, Bita Fakhri, Marc S. Hoffmann, Francisco Hernandez‐Ilizaliturri, Andrew D. Zelenetz, Anita Kumar, Talha Munir, Donald E. Tsai, Paolo Abada, Minna Balbas, Jian Li, Denise Wang, Lindsey E. Roeker, Toby A. Eyre +36 morewiley +1 more sourcePrognostic Impact of FLT3‐ITD Allelic Ratio in AML Patients Treated With High‐Dose Anthracycline and a FLT3 Inhibitor
American Journal of Hematology, EarlyView.ABSTRACT
The prognostic value of FLT3 internal tandem duplication (FLT3‐ITD) in acute myeloid leukemia (AML) has traditionally been stratified according to the ITD/wild‐type allelic ratio (AR) and NPM1 co‐mutation status. We evaluated the prognostic impact of FLT3‐ITD AR in 459 newly diagnosed AML patients younger than 60 years enrolled in the ...Mathieu Leclerc, Etienne Audureau, Nicolas Duployez, Mathilde Hunault, Emmanuelle Tavernier, Cécile Pautas, Sarah Bertoli, Emmanuel Raffoux, Marie‐Anne Hospital, Tony Marchand, Maël Heiblig, Sylvain Chantepie, Martin Carre, Pierre Peterlin, Maria‐Pilar Gallego‐Hernanz, Romain Guieze, Célestine Simand, Pascal Turlure, Anne Huynh, Emilie Lemasle, Ludovic Gabellier, Juliette Lambert, Felipe Suarez, Samy Chraibi, Laurence Sanhes, Karine Celli‐Lebras, Ariane Mineur, Claude Gardin, Jean‐Valère Malfuson, Thomas Cluzeau, Norbert Vey, Régis Peffault de Latour, Lucie Rigolot, Isabelle Luquet, Dominique Penther, Raphael Itzykson, Eric Delabesse, Jean‐François Hamel, Stéphane de Botton, Arnaud Pigneux, Hervé Dombret, Claude Preudhomme, Christian Recher, Pierre‐Yves Dumas +43 morewiley +1 more sourceEarly mepolizumab initiation during remission induction is associated with lower organ damage burden in EGPA: a multicentre cohort study. [PDF]
Rheumatology (Oxford)Maruyama A, Ono N, Kai T, Kimoto Y, Nakano M, Inoue Y, Ueda N, Miyamura T, Otsuka K, Shinkawa Y, Tada Y, Akahoshi M, Niiro H. +12 moreeuropepmc +1 more sourceCharacteristics Associated With Persistent Long COVID Symptoms in Healthcare Personnel Infected With SARS‐CoV‐2 Between August 2022 and May 2024: A Multicenter Cohort Analysis of US Healthcare Personnel
American Journal of Industrial Medicine, EarlyView.ABSTRACT Background
Long COVID affects a significant proportion of COVID‐19 survivors. This study examined persistent Long COVID symptoms among healthcare personnel (HCP) and evaluated associations with vaccination, prior SARS‐CoV‐2 infection, underlying health conditions, and demographics.Eric Kontowicz, Amanda K. Irish, Lilly C. Lee, Howard A. Smithline, Ian D. Plumb, Melissa Briggs‐Hagen, Alexandra F. Rollins, Karisa K. Harland, Anusha Krishnadasan, Karin F. Hoth, Eliezer Santos‐León, David A. Talan, Nicholas M. Mohr, Project PREVENT Network +13 morewiley +1 more sourceEx vivo JAK and TNF inhibitor-modulated immune signatures guide first-line therapy selection in rheumatoid arthritis. [PDF]
Biomark ResCorrales S, Pérez-Sánchez C, Cerdó T, Merlo C, Malvar-Fernández B, García S, Muñoz-Barrera L, Sanchez-Pareja I, Formanti L, Moreno-Caño E, Ortega-Castro R, Calvo J, Aranda-Varela C, Ladehesa L, Font P, Abalos-Aguilera MC, Ruiz-Vilchez D, Aguirre MÁ, Barbarroja N, Alarcon-Riquelme ME, Escudero-Contreras A, López-Pedrera C. +21 moreeuropepmc +1 more sourceConstruction Trade Work Is Associated With Accelerated Decline in Kidney Function
American Journal of Industrial Medicine, EarlyView.ABSTRACT Background
Construction workers are exposed to airborne particulates, organic solvents, and metals—agents linked to elevated risk of chronic kidney disease (CKD). Few studies have evaluated whether construction trade work is associated with longitudinal changes in estimated glomerular filtration rate (eGFR), a key indicator of kidney function. Sammy Almashat, John M. Dement, Marianne Cloeren, Knut Ringen, Miles Fisher, Richard Rinehart +5 morewiley +1 more sourceFirst-line biologic and targeted synthetic DMARDs versus methotrexate in early rheumatoid arthritis: a meta-analysis of remission outcomes. [PDF]
Rheumatology (Oxford)Russell MD, Chan CJ, Sasitharan A, Allen V, Gibson M, Adas MA, Goodliffe S, Bechman K, Cope AP, Norton S, Bosworth A, Foxton P, Price E, Sharrack S, Dass S, Emery P, Kay L, Lanyon P, Galloway JB. +18 moreeuropepmc +1 more source